The Effect of Vardibel (Rosa canina) and Pardihan syrups on Symptoms of Attention Deficit Hyperactivity Disorder
Phase 3
Recruiting
- Conditions
- Hyperactivity and Inattention Disorder.Attention-deficit hyperactivity disorders
- Registration Number
- IRCT20190923044855N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Children 5-14 years old with attention deficit / hyperactivity disorder
The child was treated with methylphenidate
Lack of simultaneous use of other alternative and complementary therapies
Exclusion Criteria
mental retardation
No psychiatric disorder (bipolar disorder type 1, psychosis, autism and any comorbid and using separate treatment).
Chronic physical illness, including organic cerebral problems or seizures.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of attention deficit / hyperactivity disorder based on the questionnaire score. Timepoint: The first day of receiving the drug (0), 4 and 8 weeks from the start of the drug. Method of measurement: Conners Scale (Home and School Version),CSI4,Temperment questionaire.
- Secondary Outcome Measures
Name Time Method Quality of life and Side Effects of Nastaran and Pardihan Syrups. Timepoint: Outcome assessment at the beginning of the study, the fourth week and the eighth week, is done 3 times in total. Method of measurement: Conners , CSI4 and Temperment questionnaires.